Malaria, Falciparum: all 390 studies
Page 4 of 4. Open to participants first (35), then studies with results posted, then the rest; newest registration first within each.
- Effectiveness of Artemisinin Combination Regimens in Falciparum MalariaStatus unknownNCT00902811Phase 4
- A Bioequivalence Study Comparing Amodiaquine Tablet (Pfizer) To Amodiaquine Tablets (Arsuamoon-Guilin China) In Healthy SubjectsCompletedNCT00894660Phase 1
- Bioequivalence Study Comparing Artesunate Tablet To Arsuamoon® Tablets (Guilin-China) In Healthy SubjectsCompletedNCT00894374Phase 1
- Phase I Study of the Safety and Immunogenicity of BSAM-2/Alhydrogel +CPG 7909, an Asexual Blood Stage Vaccine for Plasmodium Falciparum Malaria in Adults in the US and MaliCompletedNCT00889616Phase 1
- Interactions Between Artemether-lumefantrine and Antiretrovirals in HIV-patients With Uncomplicated Malaria in TanzaniaCompletedNCT00885287Phase 4
- A Bioequivalence Study Comparing Camoquin® Suspension (Pfizer) To Flavoquine® Tablets (Sanofi Aventis) In Healthy SubjectsCompletedNCT00859807Phase 4
- Re-exposure of EHMI-8 Human Volunteers to Live Malaria SporozoitesCompletedNCT00757887Not applicable
- Assessment of Three Formulations of the Candidate Vaccine AMA 1 in Healthy Dutch Adult VolunteersCompletedNCT00730782Phase 1
- Artemisinin Resistance in Cambodia IICompletedNCT00722150Not applicable
- Evaluation of Safety and Efficacy of Artemether-Lumefantrine Tablets in African Infants and Children With Uncomplicated P. Falciparum MalariaCompletedNCT00709969Phase 3
- The Cytoadherence in Pediatric Malaria (CPM) StudyCompletedNCT00707200
- Pharmacokinetic of Mefloquine-Artesunate in Plasmodium Falciparum Malaria Infection in PregnancyCompletedNCT00701961Phase 2/3
- Cohort Study in Uganda Comparing Artesunate + Amiodaquine (Coarsucam) Versus Artemether + Lumenfantrine (Coartem) in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria AttacksCompletedNCT00699920Phase 4
- Evaluation of Volume Status, Haemodynamics and Microcirculatory Flow in Adult Patients With Severe Falciparum MalariaCompletedNCT00692627
- A Comparative Study of Artekin With Standard Malarial Treatment Regimes in AfghanistanCompletedNCT00682578Phase 3
- Innate and Acquired Resistance to Plasmodium Falciparum Malaria in MaliCompletedNCT00669084
- Safety and Preliminary Efficacy of L-arginine in Severe Falciparum MalariaSuspendedNCT00616304Phase 2
- Malarial Immunity in Pregnant Cameroonian WomenCompletedNCT00593398
- ICC-1132 - Candidate Vaccine Against P Falciparum MalariaCompletedNCT00587249Phase 1
- Cohort Study in Senegal Comparing Artesunate + Amiodaquine in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria AttacksCompletedNCT00540410Phase 4
- Randomised Efficacy Study of Two Artemether-Lumefantrine Oral Formulations for the Treatment of Uncomplicated P. Falciparum MalariaCompletedNCT00529867Phase 4
- Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in TanzaniaCompletedNCT00513669Phase 1
- Mass-Drug Administration to Reduce Malaria TransmissionCompletedNCT00509015Not applicable
- Clinical Investigation of In-vivo Susceptibility of P.Falciparum to Artesunate in Western CambodiaCompletedNCT00493363Not applicable
- Multi-Centre Trial Comparing Three Artemisinin-Based Combination Treatments on P. Falciparum MalariaCompletedNCT00484900Phase 3
- Artemisinin Resistance in CambodiaCompletedNCT00479206Not applicable
- Plasmodium Resistance in A. GambiaeCompletedNCT00466557
- Tolerability and Efficacy of CD+A Compared to AQ+SP for the Treatment of P.Falciparum Malaria in Rwandan ChildrenCompletedNCT00461578Not applicable
- Phase II Dose Ranging Study of ArtesunateCompletedNCT00459615Phase 2
- Study to Investigate the Induction of an Protective Immune Response to MalariaCompletedNCT00442377Not applicable
- The Impact of Artemether-Lumefantrine on Genes Associated With Antimalarial ResistanceCompletedNCT00440752
- Chloroquine and Coartem for Treatment of Symptomatic Children With Plasmodium Falciparum in Guinea BissauCompletedNCT00426439Phase 4
- Efficacy of Amodiaquine-artesunate in Children Aged 6-59 Months With Uncomplicated P. Falciparum MalariaCompletedNCT00425763Phase 4
- Efficacy of Combined PEV3A Virosomal Vaccine and FP9-MVA ME-TRAP Prime Boost RegimenCompletedNCT00408668Phase 1/2
- Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated PeptidesTerminatedNCT00400101Phase 1
- Malaria Transmission and Immunity in Highland KenyaCompletedNCT00393757
- Efficacy and Safety of the Pediatric Formulation of Artemether- Lumefantrine in Children With Uncomplicated P. Falciparum Malaria.CompletedNCT00386763Phase 3
- Efficacy, Effect on Gametocytes and Tolerability of the Addition of Artesunate to Amodiaquine in ColombiaCompletedNCT00378625Phase 3
- CS DNA MVA Trial in Mampong, GhanaWithdrawnNCT00377494Phase 1
- Sporozoite Challenge of Polyprotein VaccineesCompletedNCT00375128Phase 1/2
- Safety and Immunogenicity Study of the Malaria Vaccines FP9 PP and MVA PPCompletedNCT00374998Phase 1
- Randomized Trial on Effectiveness of ACTs in GhanaTerminatedNCT00374205Phase 4
- Chlorproguanil-Dapsone-Artesunate (CDA) Versus Chlorproguanil-Dapsone (LAPDAP) For Uncomplicated MalariaCompletedNCT00371735Phase 3
- Azithromycin Plus Chloroquine Versus Mefloquine In the Treatment of Uncomplicated P. Falciparum Malaria.CompletedNCT00367653Phase 3
- RBx11160 Phase II Dose Ranging Study RBx/MMV05-06CompletedNCT00362050Phase 2
- Azithromycin Combination Therapy for the Treatment of Uncomplicated Falciparum Malaria in BangladeshCompletedNCT00356005Phase 2
- Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered IntramuscularlyCompletedNCT00347555Phase 1
- AMA1-C1/Alhydrogel + CpG 7909 for MalariaCompletedNCT00344539Phase 1
- Chlorproguanil-Dapsone-Artesunate Versus COARTEM For Uncomplicated MalariaCompletedNCT00344006Phase 3
- Experimental Vaccine for Malaria in Adults in MaliCompletedNCT00343005Phase 1
- Experimental Vaccine for Plasmodium Falciparum MalariaCompletedNCT00340431Phase 1
- Hyperphenylalaninemia in Cerebral MalariaCompletedNCT00338520
- Investigation of the Efficacy of Quinine Sulphate Administered Via Taste-Masked Pellets to Children With Falciparum MalariaCompletedNCT00329134Phase 2
- Malaria Prevalence in ChildrenCompletedNCT00322816
- Time to Infection With Malaria ParasitesCompletedNCT00322738
- ATAQ EASY: Artesunate + Amodiaquine Fixed Dose Combination in the Treatment of Uncomplicated Plasmodium Falciparum MalariaCompletedNCT00316329Phase 3
- Fetal Immunity to Falciparum MalariaCompletedNCT00314899
- Comparative Evaluation of the Safety and the Efficacy of 2 Antimalarials Depending on HIV StatusTerminatedNCT00304980Not applicable
- Rapid Diagnostic Testing and Artemisinin-Based Combination Therapy for Uncomplicated Malaria by Community Health WorkersCompletedNCT00301015Phase 4
- SP Resistance and Falciparum Malaria TransmissionWithdrawnNCT00299247Phase 3
- Azithromycin Combination Therapy for MalariaCompletedNCT00299208Phase 2
- Effect of Antimalarial Treatment on Gametocyte Carriage in Asymptomatic P. FalciparumCompletedNCT00289250Phase 3
- A Study of Safety and Immunogenicity of a Malaria Vaccine CandidateCompletedNCT00284973Phase 1
- Efficacy of Amodiaquine in the Treatment of Uncomplicated Falciparum Malaria in Young Children of Burkina FasoCompletedNCT00261222Phase 2
- Efficacy, Safety and Pharmacokinetic of ArtequinTM P. Falciparum MalariaCompletedNCT00243737Phase 2
- Efficacy, Safety and Tolerability of Co-artemether in Non-immune TravelersCompletedNCT00233337Phase 4
- Efficacy of Chloroquine + Sulfadoxine Pyrimethamine Versus Artemether + Lumefantrine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in the PhilippinesCompletedNCT00229775Not applicable
- Assessing the Efficacy of Four Drug Combinations as the Next First-line Therapy for Uncomplicated Malaria in MalawiCompletedNCT00164710Phase 4
- Amodiaquine Plus Artesunate Versus Lapdap Plus Artesunate in the Treatment of Uncomplicated P. Falciparum Malaria in MalawiCompletedNCT00164359Phase 4
- Efficacy and Effectiveness of Combined Therapy for Uncomplicated Malaria Treatment in PeruCompletedNCT00164216
- ACT With Chloroquine, Amodiaquine & Sulphadoxine-pyrimethamine in PakistanCompletedNCT00158548Phase 3
- A Randomised Trial of Artekin and Artesunate & Amodiaquine for Uncomplicated Malaria in Timika, Papua, Indonesia.CompletedNCT00157885Not applicable
- To Evaluate Current Efficacy of Antimalarials Used in Timika, Papua, IndonesiaCompletedNCT00157859Not applicable
- A Randomized Trial of Coartemether and Artekin for the Treatment of Uncomplicated Malaria in Papua, Indonesia.CompletedNCT00157833Not applicable
- The Community Effectiveness of IPTi in Southern TanzaniaStatus unknownNCT00152204Phase 3
- Safety and Efficacy Study of Adjunctive Rosiglitazone in the Treatment of Uncomplicated Falciparum MalariaCompletedNCT00149383Phase 1/2
- Arginine Malaria Trial: Study of Adjunctive Arginine in Falciparum MalariaCompletedNCT00147368Phase 1/2
- Study of the Impact of Intermittent Preventive Treatment in Schools on Malaria, Anaemia and Education.CompletedNCT00142246Phase 3
- Preventing Malaria During Pregnancy in Epidemic-prone Areas.CompletedNCT00142207Phase 3
- Human Immunity to MSP-1 in Western KenyaCompletedNCT00138372
- The Efficacy of Re-treatment With Sulfadoxine-pyrimethamine in ChildrenCompletedNCT00137553Phase 4
- Chloroquine and Amodiaquine for Treatment of Malaria in ChildrenCompletedNCT00137514Phase 4
- Pentoxifylline in Children With MalariaTerminatedNCT00133393Phase 2
- Prevention of Malaria During Pregnancy Using Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: MalawiCompletedNCT00126906Not applicable
- CQSP in Malawi: Chloroquine and Sulfadoxine-pyrimethamine Efficacy for the Treatment of Malaria in MalawiCompletedNCT00125489Phase 4
- Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine For The Treatment Of Uncomplicated, Symptomatic Falciparum Malaria In Southeast AsiaTerminatedNCT00084240Phase 2/3
- Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South AmericaCompletedNCT00084227Phase 2/3
- Azithromycin Plus Chloroquine Versus Mefloquine for the Treatment of Uncomplicated Malaria in AfricaCompletedNCT00082576Phase 2/3
- Azithromycin in Combination With Chloroquine Versus Chloroquine in the Eradication of Asymptomatic Plasmodium FalciparumTerminatedNCT00082563Phase 2
- Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine for the Treatment of Uncomplicated Malaria in IndiaCompletedNCT00074841Phase 2/3